YUPELRI 175 ug/3mL
revefenacin · SOLUTION · Viatris Specialty LLC
No Recall History
Plain English
YUPELRI is a solution containing revefenacin at 175 ug/3mL, taken respiratory (inhalation). Manufactured by Viatris Specialty LLC.
Key Facts
- Brand Name
- YUPELRI
- Generic Name
- revefenacin
- NDC Code (Product)
49502-806- Manufacturer
- Viatris Specialty LLC
- Strength
- 175 ug/3mL
- Dosage Form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- NDA210598
- Drug Class
- Anticholinergic [EPC]
- Marketing Start
- 12/03/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is YUPELRI used for?
YUPELRI contains revefenacin. It is a solution taken respiratory (inhalation). Consult your doctor for specific uses.
Is YUPELRI a controlled substance?
YUPELRI is not classified as a controlled substance by the DEA.
What is the generic name for YUPELRI?
The generic name for YUPELRI is revefenacin. There are no other listed brand versions of revefenacin.
What is the NDC code for YUPELRI 175 ug/3mL?
The NDC (National Drug Code) for YUPELRI 175 ug/3mL is 49502-806, listed by Viatris Specialty LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)